Repository logo
 

Unrepaired base excision repair intermediates in template DNA strands trigger replication fork collapse and PARP inhibitor sensitivity.

Published version

Published version
Peer-reviewed

Repository DOI


Change log

Authors

Serrano-Benitez, Almudena 
Drummond-Clarke, Lylah  ORCID logo  https://orcid.org/0009-0001-7908-7481
Russo, Lilian C 
Thomas, John Christopher 

Abstract

DNA single-strand breaks (SSBs) disrupt DNA replication and induce chromosome breakage. However, whether SSBs induce chromosome breakage when present behind replication forks or ahead of replication forks is unclear. To address this question, we exploited an exquisite sensitivity of SSB repair-defective human cells lacking PARP activity or XRCC1 to the thymidine analogue 5-chloro-2'-deoxyuridine (CldU). We show that incubation with CldU in these cells results in chromosome breakage, sister chromatid exchange, and cytotoxicity by a mechanism that depends on the S phase activity of uracil DNA glycosylase (UNG). Importantly, we show that CldU incorporation in one cell cycle is cytotoxic only during the following cell cycle, when it is present in template DNA. In agreement with this, while UNG induces SSBs both in nascent strands behind replication forks and in template strands ahead of replication forks, only the latter trigger fork collapse and chromosome breakage. Finally, we show that BRCA-defective cells are hypersensitive to CldU, either alone and/or in combination with PARP inhibitor, suggesting that CldU may have clinical utility.

Description

Funder: Cancer Research UK (CRUK); doi: http://dx.doi.org/10.13039/501100000289; Grant(s): C6563/A27322, DRCPGM\100005, C17918/A28870, A:29580, C6946/A24843

Keywords

DNA repair, DNA replication stress, DNA strand breaks, PARP-1, genome instability, Humans, Poly(ADP-ribose) Polymerase Inhibitors, DNA-Binding Proteins, Chromosome Breakage, DNA Repair, DNA Replication, DNA, Antineoplastic Agents, X-ray Repair Cross Complementing Protein 1

Journal Title

EMBO J

Conference Name

Journal ISSN

0261-4189
1460-2075

Volume Title

Publisher

Springer Science and Business Media LLC
Sponsorship
Cancer Research UK (DRCPGM\100005)
European Commission Horizon 2020 (H2020) ERC (855741)
Cancer Research UK (C6946/A24843)
Cancer Research UK (C17918/A28870)
Wellcome Trust (203144/A/16/Z)
Wellcome Trust (206388/Z/17/Z)